Induced differentiation, the cell cycle, and the treatment of cancer
Authors:
- Victoria M. RichonVRVictoria M. Richon
- Paul A. MarksPMPaul A. Marks
Open Access
- 1 January 1996
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 69 (2) , 97-102
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27Science, 1995
- The retinoblastoma protein and cell cycle controlCell, 1995
- Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members.Genes & Development, 1995
- Differential regulation of E2F transactivation by cyclin/cdk2 complexes.Genes & Development, 1994
- DP and E2F proteins: components of a heterodimeric transcription factor implicated in cell cycle controlCurrent Opinion in Cell Biology, 1994
- p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.Genes & Development, 1994
- Binding to DNA and the Retinoblastoma Gene Product Promoted by Complex Formation of Different E2F Family MembersScience, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Mammalian G1 cyclinsCell, 1993
- Negative Regulation of G1 in Mammalian Cells: Inhibition of Cyclin E-Dependent Kinase by TGF-βScience, 1993